Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Maves vs VigorMeds

Maves
Graded #88

Higher grade

vs+20.099999999999994
VigorMeds
Graded #484

Lower grade

The verdict

Maves takes it — 71.8/100 to 51.7/100.

Maves grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging, with…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaves +39
84
45
Dose & formulationMaves +25
65
40
Clinical oversightMaves +6
76
70
Labs & monitoringVigorMeds +1
52
53
FulfillmentMaves +27
87
60
Contract termsMaves +14
55
41
Maves · left barVigorMeds · right bar

The numbers

MetricMavesVigorMeds
WeighScore71.8/10051.7/100
GradeCC
Scorecard rank#88#484
Semaglutide$99/mo (starting dose, first-month rate, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Maves

Graded #88 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed
VigorMeds

Graded #484 · C

Strengths

  • Provider-guided GLP-1 weight management via a telehealth consultation, not a pure async questionnaire
  • Care delivered by named, experienced clinicians (Dr. Anthony Kane, Dr. Kevin Kargman, Stephanie Kowatch FNP-C)
  • No-questions-asked 30-day satisfaction guarantee
  • Multi-vertical platform — also offers anti-aging/wellness, ED, and hair-loss treatment
  • Personalized treatment plan with ongoing follow-up and support

Where it loses points

  • Pricing not shown until you create an account and complete the intake
  • Specific GLP-1 medications and forms are not named on the public site
  • States served are not listed on an accessible page
  • Vigormeds LLC is a patient-management platform; prescribing is via OLA Health LLC and independent providers
  • No LegitScript certification or pharmacy-partner details published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard